Shares of DexCom (NASDAQ:DXCM) increased 1% in after-market trading after the company reported Q2 results.
Earnings per share were up 887.50% year over year to $0.79, which beat the estimate of $0.35.
Revenue of $451,800,000 rose by 34.30% year over year, which beat the estimate of $415,390,000.
Earnings guidance hasn't been issued by the company for now.
The upcoming fiscal year's revenue expected to be between $1,850,000,000 and $1,850,000,000.
How To Listen To The Conference Call
Date: Jul 28, 2020
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/e6y8exrx
Company's 52-week high was at $446.50
52-week low: $138.28
Price action over last quarter: Up 22.44%
Dexcom designs and commercializes continuous glucose monitoring (CGM) systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company sells three different pieces of equipment, a sensor, a transmitter, and a receiver.
See more from Benzinga
- Earnings Scheduled For July 28, 2020
- Stocks That Hit 52-Week Highs On Monday
- Stocks That Hit 52-Week Highs On Tuesday
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.